Neovasc Completes $2 Million Non-Brokered Private...(the regions in which the Company operate...),Health

Date:4/24/2009

the regions in which the Company operates; history of losses and lack of and uncertainty of revenues, ability to obtain required financing, receipt of regulatory approval of product candidates, ability to properly integrate newly acquired businesses, technology changes; competition; changes in business strategy or development plans; the ability to attract and retain qualified personnel; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; liability and other claims asserted against the Company; and other factors referenced in the Company's filings with Canadian securities regulators. Although the Company believes that expectations conveyed by the forward-looking statements are reasonable based on the information available to it on the date such statements were made, no assurances can be given as to the future results, approvals or achievements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company does not assume the obligation to update any forward-looking statements except as otherwise required by applicable law.

'/>"/>

SOURCE Neovasc Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Neovasc Inc. Reports Year 2008 Financial Results
2. Neovasc to Raise $2 Million in Non-Brokered Private Placement
3. Neovasc Receives CE Mark Approval for Peripatch(TM) Aegis Staple Line Reinforcement Product
4. Neovasc Announces Agreement With LeMaitre Vascular for Exclusive Distribution Rights to its Biological Vascular Strips
5. Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results
6. Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options
7. Facet Solutions Completes 1 Year Follow-up on U.S. Pilot Study
8. Halo Pharmaceutical Completes $14.6 Million in Financing from The Provident Bank
9. Pharmos Completes Private Placement - Raises $1.8 Million
10. Transave Completes Enrollment in Arikace(TM) Phase II Bronchiectasis Study
11. Tianyin Pharmaceutical Co. Inc.s Ginkgo Mihuan Oral Solution Completes 2009 Tenders